120 related articles for article (PubMed ID: 9771615)
1. Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver.
Melgert BN; Wartna E; Lebbe C; Albrecht C; Molema G; Poelstra K; Reichen J; Meijer DK
J Drug Target; 1998; 5(5):329-42. PubMed ID: 9771615
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK
J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
[TBL] [Abstract][Full Text] [Related]
4. Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis.
Albrecht C; Meijer DK; Lebbe C; Sägesser H; Melgert BN; Poelstra K; Reichen J
Hepatology; 1997 Dec; 26(6):1553-9. PubMed ID: 9397997
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between naproxen, naproxen-protein conjugates, and naproxen-lysine in plasma via micellar electrokinetic capillary chromatography--a new approach in the bioanalysis of drug targeting preparations.
Albrecht C; Reichen J; Visser J; Meijer DK; Thormann W
Clin Chem; 1997 Nov; 43(11):2083-90. PubMed ID: 9365392
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
Franssen EJ; van Amsterdam RG; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
Pharm Res; 1991 Oct; 8(10):1223-30. PubMed ID: 1796038
[TBL] [Abstract][Full Text] [Related]
7. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
Poulin P; Bteich M; Haddad S
J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
[TBL] [Abstract][Full Text] [Related]
8. Targeting naproxen to non-parenchymal liver cells protects against endotoxin induced liver damage.
Lebbe C; Reichen J; Wartna E; Sägesser H; Poelstra K; Meijer DK
J Drug Target; 1997; 4(5):303-10. PubMed ID: 9169987
[TBL] [Abstract][Full Text] [Related]
9. Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver.
Lo A; Addison RS; Hooper WD; Dickinson RG
Xenobiotica; 2001 Jun; 31(6):309-19. PubMed ID: 11513245
[TBL] [Abstract][Full Text] [Related]
10. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective binding properties of naproxen glucuronide diastereomers to proteins.
Bischer A; Zia-Amirhosseini P; Iwaki M; McDonagh AF; Benet LZ
J Pharmacokinet Biopharm; 1995 Aug; 23(4):379-95. PubMed ID: 8882746
[TBL] [Abstract][Full Text] [Related]
12. Predictions of bisphenol A hepatic clearance in the isolated perfused rat liver (IPRL): impact of albumin binding and of co-administration with naproxen.
Bounakta S; Bteich M; Mantha M; Poulin P; Haddad S
Xenobiotica; 2018 Feb; 48(2):135-147. PubMed ID: 28277163
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
Franssen EJ; Moolenaar F; de Zeeuw D; Meijer DK
Pharm Res; 1993 Jul; 10(7):963-9. PubMed ID: 8378258
[TBL] [Abstract][Full Text] [Related]
14. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.
Kamps JA; Morselt HW; Swart PJ; Meijer DK; Scherphof GL
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11681-5. PubMed ID: 9326670
[TBL] [Abstract][Full Text] [Related]
15. Disease-induced drug targeting using novel peptide-ligand albumins.
Meijer DK; Beljaars L; Molema G; Poelstra K
J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
[TBL] [Abstract][Full Text] [Related]
16. Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats.
Melgert BN; Olinga P; Van Der Laan JM; Weert B; Cho J; Schuppan D; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 2001 Oct; 34(4 Pt 1):719-28. PubMed ID: 11584368
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells.
Melgert BN; Olinga P; Jack VK; Molema G; Meijer DK; Poelstra K
J Hepatol; 2000 Apr; 32(4):603-11. PubMed ID: 10782909
[TBL] [Abstract][Full Text] [Related]
18. Chemical reactivity of the naproxen acyl glucuronide and the naproxen coenzyme A thioester towards bionucleophiles.
Olsen J; Bjørnsdottir I; Tjørnelund J; Honoré Hansen S
J Pharm Biomed Anal; 2002 Jun; 29(1-2):7-15. PubMed ID: 12062660
[TBL] [Abstract][Full Text] [Related]
19. Naproxen-induced oxidative stress in the isolated perfused rat liver.
Yokoyama H; Horie T; Awazu S
Chem Biol Interact; 2006 Mar; 160(2):150-8. PubMed ID: 16472794
[TBL] [Abstract][Full Text] [Related]
20. Absorption and distribution of naproxen in rats orally treated with naproxen betainate sodium salt monohydrate. Comparison with naproxen.
Marzo A; Ripamonti M; Benatti P; Marzo P; Wool C; Cerutti R; Reiner V
Arzneimittelforschung; 1997 Apr; 47(4):381-4. PubMed ID: 9150857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
